COMPOSITION : Each Hard Gelatin capsules contains: Sunitinib Malate 12.5 mg
INDICATION:
- SUTEKAST is Indicated for treatment of Gastrointestinal Stromal Tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
- SUTEKAST is indicated for the treatment of pancreatic cancer kn own a s pancreatic neuroendocrine tumors (pNET) that ha s progressed and cannot be treated with surgery or metastatic disease
- SUTEKAST is also indicated for the treatment of advanced kidney carcinoma.
PACKING: 4X7 / capsules
